Jinhong Feng

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Jing He, Xia Zhang, Yunbo Wei et al. · Nature Medicine · 2016 · 572 citations

Life Sciences, Immunology, Autoimmunity +15

Development of Tetrahydroisoquinoline-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities

Yingjie Zhang, Jinhong Feng, Yuping Jia et al. · Journal of Medicinal Chemistry · 2011 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

An in vitro AChE inhibition assay combined with UF-HPLC-ESI-Q-TOF/MS approach for screening and characterizing of AChE inhibitors from roots of Coptis chinensis Franch

Hengqiang Zhao, Siduo Zhou, Minmin Zhang et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 63 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +9

Discovery of a Tetrahydroisoquinoline-Based Hydroxamic Acid Derivative (ZYJ-34c) as Histone Deacetylase Inhibitor with Potent Oral Antitumor Activities

Yingjie Zhang, Hao Fang, Jinhong Feng et al. · Journal of Medicinal Chemistry · 2011 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors

Yingjie Zhang, Jinhong Feng, Chunxi Liu et al. · Bioorganic & Medicinal Chemistry · 2010 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12